Related by context. All words. (Click for frequent words.) 76 humanized monoclonal antibody 72 humanized antibody 71 monoclonal antibody 70 antibody MAb 68 IgG1 antibody 67 investigational humanized monoclonal antibody 66 humanized monoclonal antibodies 66 antibody 66 soluble tumor necrosis 66 monoclonal antibodies 65 drug conjugate 65 human antibody therapeutics 65 humanized anti 65 antibody fragment 65 monoclonal antibodies MAbs 65 PSMA antibody 64 anti CD# antibody 64 chimeric monoclonal antibody 64 orally bioavailable 64 proteasome inhibitor 64 potent inhibitor 64 selective inhibitor 64 selective kinase inhibitor 64 multi kinase inhibitor 64 oncolytic 63 HCD# [002] 63 Ofatumumab 63 AEG# 63 MT#/MEDI-# 63 HCV NS3 protease 63 targeting CD# 63 small molecule inhibitor 63 Fc fusion protein 62 antisense drug 62 oral prodrug 62 factor TNF receptor 62 IAP inhibitors 62 novel peptide 62 protein tyrosine phosphatase 1B 62 novel topoisomerase 62 humanized monoclonal 62 chemically modified siRNA 62 sodium glucose cotransporter 62 IMA# 62 M2 subunit 62 neuraminidase inhibitor 62 recombinant adeno associated 62 targeted antifolate 62 HCV protease 62 fusion protein 62 novel antibody therapeutics 62 Tesetaxel 62 CTLA 4 62 angiogenesis inhibitor 61 immunomodulator 61 Factor VIIa 61 tyrosine kinase inhibitor 61 IgG1 monoclonal antibody 61 selective agonist 61 Tarvacin TM 61 therapeutic antibody 61 Sym# 61 small molecule inhibitors 61 PKC# 61 synthetic peptide 61 PEGylated 61 erlotinib Tarceva ® 61 siRNA therapeutic 61 targeted radiotherapeutic 61 ADP receptor antagonist 61 agonistic human 61 mertansine 61 GM CSF 61 protein kinase inhibitor 61 FGFR 61 recombinant subunit vaccine 61 investigational monoclonal antibody 61 HCV protease inhibitor 61 IMC #B 61 PDE4 inhibitor 61 PEGylated Fab fragment 61 anti CD3 monoclonal 61 anti EGFR antibody 61 CYC# 60 selective orally bioavailable 60 mAb 60 peripherally acting 60 JAK1 60 delivered RNAi therapeutic 60 histone deacetylase HDAC 60 ketolide antibiotic 60 MAb 60 histone deacetylase HDAC inhibitor 60 pan HDAC inhibitor 60 B lymphocyte stimulator 60 Bavituximab 60 hypoxia inducible factor 60 NTDDS 60 AVP #D# 60 IAP inhibitor 60 epothilones 60 polymerase inhibitor 60 Tarvacin 60 Epothilones 60 fusion proteins 60 XmAb TM 60 HSP# inhibitor 60 PRT# 60 human IgG2 monoclonal 60 prophylactic vaccine 60 ALN VSP 60 cancer vaccine Norelin 60 MT# MEDI 60 epothilone 60 ErbB3 60 VitiGam 60 Alfacell proprietary ribonuclease 60 kinase inhibitor 60 therapeutic monoclonal antibody 60 humanised monoclonal antibody 60 humanized antibodies 60 immunostimulatory 60 Panzem R 60 aptamer 60 chimeric antibodies 60 pharmacological chaperone 60 MEK inhibitor 60 Intravenous Human 60 chemotherapeutic agent 60 PNP inhibitor 60 investigational antibody 60 mAbs 60 antibody MT# 60 somatostatin analogue 60 prodrug 59 imatinib Gleevec ® 59 therapeutic antibodies 59 Vicinium TM 59 taxane derivative 59 liposomal formulation 59 oral Janus kinase 59 EGFr 59 BCR ABL inhibitors 59 polyclonal antibody 59 huC# DM4 59 Vidofludimus 59 Maribavir 59 immunotherapeutic agent 59 UsiRNAs 59 investigational pan BCR 59 TLR9 agonist 59 poly ADP ribose polymerase 59 BAL# [001] 59 systemic RNAi therapeutic 59 oral Factor Xa 59 tumor antigen 59 HGS ETR2 59 dependent cellular cytotoxicity 59 HuCAL antibody 59 Nanobody 59 oral antiviral 59 MOR# 59 selective antagonist 59 Onconase 59 T#I mutant 59 BiTE 59 Pradefovir 59 polymerase inhibitors 59 monoclonal antibody mAb 59 NPC 1C 59 MTP inhibitor 59 generation antisense 59 Pralatrexate 59 isoform selective 59 antisense drugs 59 orally administered inhibitor 59 mitogen activated ERK kinase 59 small molecule glucokinase 59 JAK inhibitor 59 CCX# 59 histone deacetylase inhibitor 59 dasatinib Sprycel ® 59 therapeutic monoclonal antibodies 59 VEGF receptor 59 MVA BN R 59 mediate antibody 59 peptidic compound 59 MKC# MT 59 immune modulator 59 depsipeptide 59 immunotoxin 59 cytotoxin 59 luteinizing hormone releasing 59 HCV polymerase 59 OncoVEX GM CSF 59 highly selective inhibitor 59 PEG Interferon lambda 59 Locked Nucleic Acid 59 non nucleoside inhibitor 59 immunotherapeutic 59 murine mouse 59 sphingosine 1 58 XmAb 58 peptibody 58 peptide antigens 58 Blinatumomab 58 mu opioid receptor antagonist 58 CD4 monoclonal antibody 58 Janus kinase 58 Elotuzumab 58 Aurora kinase 58 CD# antibody [001] 58 HuLuc# 58 anti phosphatidylserine 58 MORAb 58 TRAIL receptor 58 small molecule 58 nanoviricide 58 XmAb ® 58 GV# [001] 58 OncoVex 58 stable nucleic acid 58 EGF receptor 58 HQK 58 selective modulator 58 chemokine receptor 58 bispecific 58 Medarex UltiMAb R 58 Zalypsis 58 AGS PSCA 58 CCR9 antagonist 58 alpha folate receptor 58 inhaled formulation 58 SAR# [004] 58 anticancer compound 58 subcutaneous formulation 58 monoclonal antibody MAb 58 myelofibrosis polycythemia vera 58 irreversible inhibitor 58 RNAi therapeutic 58 selective inhibition 58 small molecule tyrosine 58 oncolytic virus 58 RNAi therapeutic targeting 58 camptothecin 58 Fleximer 58 murine monoclonal antibody 58 XmAb# 58 ALN PCS 58 investigational immunotherapy 58 tkRNAi 58 CYT# potent vascular disrupting 58 Talabostat 58 XL# XL# 58 HER2/neu 58 ALN TTR 58 virus AAV 58 IL #E 58 anti secretory 58 anticancer agent 58 reslizumab 58 vaccine adjuvant 58 preclinical compounds 58 Amigal 58 anti CD3 58 Preclinical studies suggest 58 Zolinza 58 Olaparib 58 Tumor necrosis factor 58 A3 adenosine receptor 58 Factor Receptor 58 Elvitegravir 58 RAV# 58 vaccine GRNVAC1 58 HGS ETR1 mapatumumab 58 TKM PLK1 58 SGLT2 58 organ transplant rejection 57 CCR5 antagonist 57 Anticalins R 57 antibodies 57 CD# monoclonal antibody 57 immunomodulating 57 virosome 57 nucleoside analogue 57 Epratuzumab 57 Valortim 57 HCV polymerase inhibitors 57 oral dihydropyrimidine dehydrogenase DPD 57 proprietary BiTE ® 57 potent cytotoxic 57 lysophosphatidic acid LPA 57 OncoVEX 57 Elesclomol 57 CD# molecule 57 VEGF Trap 57 polysaccharide polymer 57 Sphingomab 57 delta isoform 57 BiTE antibody 57 PLK1 SNALP 57 antisense oligonucleotide 57 rHuPH# recombinant human 57 JAK3 57 HER1 57 anti CD# monoclonal 57 JAK2 inhibitor 57 INGN 57 HER3 57 herpes simplex viruses 57 SPC# [001] 57 CCR2 57 factor G CSF 57 hormone LHRH antagonist 57 cytotoxic T 57 NS4A 57 Tyrima 57 recombinant fusion 57 CD# antigen 57 Hedgehog signaling pathway 57 AAG geldanamycin analog 57 Epidermal Growth Factor Receptor 57 Factor Xa inhibitor 57 MVA BN 57 GRN#L 57 Ustekinumab 57 cytomegalovirus CMV 57 CEQ# 57 NEUGENE 57 Panitumumab 57 methionine aminopeptidase 57 Linaclotide 57 anti botulism antibody 57 MMAE 57 otelixizumab 57 proteasome inhibitors 57 HuMax CD# 57 INS# [001] 57 ALN TTR# 57 MET VEGFR2 57 MAbs 57 cutaneous T 57 lipopeptide 57 ocular formulation 57 long acting muscarinic 57 CXCR4 receptor 57 protein mTOR 57 prophylactic vaccines 57 Nexavar ® 57 siRNA compounds 57 Dapagliflozin 57 OXi# 57 Daclizumab 57 Pathway Inhibitor 57 thymalfasin 57 HepaGam B 57 immune modulators 57 PI3K/Akt pathway inhibitor 57 ANG# 57 cutaneous T cell 57 CD3 monoclonal antibody 57 Monoclonal Antibody 57 PORxin TM 57 JAK inhibitors 57 Ocrelizumab 57 Squalamine 57 investigational drug 57 TKB# 57 Traficet EN 57 phosphoinositide 3 57 DNA intercalator 57 oncolytic virus therapies 57 dasatinib Sprycel 57 Pancreate 57 YONDELIS 57 selective androgen receptor modulator 57 recombinant polyclonal antibodies 57 OMP #M# 57 Methylnaltrexone 57 docetaxel Taxotere R 57 ribonucleotide reductase clinically validated 57 tyrosine kinase receptor 57 fusion inhibitors 57 selectively inhibit 57 telomerase therapeutic 56 peptidomimetic 56 radiation sensitizer 56 polyclonal antibodies 56 3 kinase PI3K 56 small molecule defensin 56 IMC A# 56 attenuated strain 56 integrin receptors 56 VEGF receptors 56 oral ghrelin agonist 56 BiTE ® 56 Locked Nucleic Acid LNA 56 anti angiogenic agent 56 highly immunogenic 56 personalized immunotherapy 56 HuCAL 56 Azedra 56 fusion inhibitor 56 IMiDs R 56 M2e 56 Aurora kinase inhibitor 56 using Crucell PER.C6 56 accumulate preferentially 56 Luteinizing Hormone Releasing Hormone 56 cancer immunotherapies 56 PTP 1B 56 DepoVax ™ 56 NY ESO 56 Aflibercept 56 MyVax R 56 bispecific antibody 56 T#I [002] 56 autologous cellular immunotherapy 56 myeloma cells 56 PEGylated anti 56 MEK inhibitors 56 Dacetuzumab 56 mitotic kinesin 56 ENMD # 56 MUC1 56 CXCR4 56 Resten NG 56 CCR5 mAb 56 Fx #A 56 AtuRNAi 56 antifungal agent 56 acetylcholinesterase AChE 56 mTOR mammalian target 56 receptor tyrosine kinase inhibitor 56 anti CTLA 56 monoclonal 56 androgen receptor AR 56 metastatic colorectal 56 cetuximab Erbitux ® 56 vascular disrupting agents 56 EpCAM 56 TREANDA 56 Tumour Vascular Disrupting Agent 56 Interferon alfa 56 DepoVax 56 Hsp# Inhibitor 56 vinca alkaloid 56 Hsp# inhibitors 56 ErbB3 HER3 56 agonist compounds 56 Solazed TM 56 PI3K inhibitor 56 immunomodulators 56 Gleevec resistant 56 CCR9 56 LymphoStat B belimumab 56 adecatumumab MT# 56 GRNVAC1 56 novel immunomodulatory 56 biologic therapy 56 HER2 antibody 56 receptor antagonist 56 FLT3 56 Nanobody ® 56 hepatitis C virus HCV 56 novel histone deacetylase 56 antisense inhibitor 56 immune stimulatory 56 recombinant antibodies 56 oncolytic viruses 56 Omacetaxine 56 selectively binds 56 flu mAb 56 candidate deforolimus 56 Valortim R 56 ABL inhibitor 56 Curaxin CBLC# 56 RhuDex ® 56 Antigenics QS 56 opioid receptor antagonist 56 TNF receptor 56 gastro intestinal inflammation 56 XmAb ™ 56 PEG SN# 56 VEGFR2 inhibitor 56 Carfilzomib 56 apoptosis proteins 56 chemotherapy induced neutropenia 56 Tumor Necrosis Factor 56 IMGN# 56 nanoviricides 56 delta opioid receptor 56 renin inhibitor 56 anionic backbone 56 TLR7 56 RECOTHROM R 56 Angiocept 56 auristatin 56 phosphate S1P 56 lipid nanoparticle 56 compound perifosine 56 cellular immunotherapy 56 non nucleoside HCV 56 Debio 56 Enkephalin 56 Genentech Rituxan 56 glycosylated 56 LEX System 56 vWF 56 docetaxel Taxotere ® 56 immunotherapeutic vaccine 56 Temsirolimus 56 biologic therapies 56 cell lymphoma CTCL 56 BiTE R 56 varicella zoster virus 56 Monoclonal antibody 56 Triphendiol 56 PEGylated interferon 56 Enzastaurin 56 Golimumab 56 AP# [003] 56 anticancer therapies 56 volociximab 56 anticancer therapeutics 56 short interfering RNA 56 anticancer compounds 56 HuMax EGFr 56 CDDO Im 56 ApoB SNALP 56 bortezomib Velcade 56 investigational oral 56 LNPs 56 reformulates existing FDA 56 BCR ABL 56 Vaxfectin 56 Archexin 56 oral JAK1 56 siRNA 56 Multimeric 56 Curaxins 56 PDGF receptor 56 Ixabepilone 56 Angiolix 56 seliciclib CYC# 56 apoptotic pathway 56 XL# anticancer compounds 56 Allovectin 7 56 Transdrug ® nanoparticle 56 meropenem 56 novel nucleoside analog 56 vascular disrupting agent 56 Cetrorelix 56 alpha interferon 56 Unit Dose Budesonide 56 EGFR inhibitors 55 synthetic retinoid 55 non nucleoside 55 HuMax TAC 55 anti TNF alpha 55 PARP inhibitors 55 anticancer agents 55 triggers apoptosis programmed 55 nicotinic alpha 7 55 tumor necrosis factor 55 tyrosine kinase inhibitors 55 nucleoside analog 55 exon skipping 55 MAGE A3 ASCI 55 Tarvacin Anti Viral 55 Nanobodies 55 HGS ETR1 55 pegylated 55 Soliris eculizumab 55 DXL# 55 RANK Ligand inhibitor 55 hemorrhagic fever viruses 55 MDRNA proprietary 55 transfection reagents 55 Liposomal 55 #D#C# 55 TNFα 55 EZN 55 histone deacetylase 55 dacetuzumab 55 TLR8 55 lintuzumab SGN 55 GLPG# 55 AAV vector 55 Laquinimod 55 HyperAcute 55 Sapacitabine 55 RNA antagonist 55 intratumoral injection 55 molecularly targeted 55 ATL# [001] 55 NS#/#A protease 55 dihydrofolate reductase 55 selective phosphodiesterase 55 Pentraxin 2 55 cyclin dependent kinase CDK 55 PD LID 55 PI3 kinase 55 potently inhibit 55 Vitaxin 55 naturally occurring protein 55 rituximab Rituxan 55 Ceflatonin 55 ProMune 55 Dicer Substrate Technology 55 VLP vaccine 55 imatinib Gleevec 55 Factor VEGF 55 PI3K/mTOR 55 JAK#/JAK# 55 Personalized Immunotherapy 55 Micromet BiTE 55 Hepatitis C virus HCV 55 specific lectin receptors 55 fluoroquinolone antibiotic 55 mTOR inhibitor 55 dAbs 55 BN# [002] 55 histone deacetylase HDAC inhibitors 55 IGF 1R 55 Romidepsin 55 potent topoisomerase II 55 Chemokine Receptor 55 Xencor XmAb 55 NXL# 55 Anticalin 55 targeting PCSK9 55 SAR# [002] 55 PARP inhibitor 55 induces antibodies 55 TH# cells 55 BRAF inhibitor 55 c MET 55 intranasal insulin product 55 mda 7 55 tubulin inhibitor 55 HepaGam B TM 55 AVI NEUGENE 55 alvespimycin 55 phage display 55 TNF α 55 Aplidin 55 glioblastoma multiforme GBM 55 NEUGENE antisense 55 TG# [001] 55 Initiates Phase II 55 kinase inhibitors 55 oral kinase inhibitor 55 INCB# [001] 55 immune modulating 55 Pertuzumab 55 BRAF kinase 55 P#X# 55 Potelligent Technology 55 5 HT2A serotonin 55 THR beta agonist 55 DOS# 55 phosphatidylserine PS targeting 55 H#N# VLP vaccine 55 fatty acid amide hydrolase 55 Sphingomab TM 55 2DG 55 factor Xa 55 systemically administered 55 Payload TAP technology 55 Litx 55 cancer immunotherapy 55 radezolid 55 Synavive 55 Oral NKTR 55 deacetylase inhibitors 55 topoisomerase 55 DsiRNA 55 clinically validated targets 55 Seliciclib 55 histone deacetylase inhibitors 55 Phase #b/#a clinical 55 CD# antibodies 55 ErbB 55 forodesine 55 Milatuzumab 55 novel RNAi therapeutics 55 RiVax 55 Voreloxin 55 Proxinium TM 55 small molecule modulators 55 HepDirect prodrug 55 delipidation 55 oncoprotein 55 mTOR kinase 55 Pazopanib 55 lentiviral vector 55 Provectus Pharmaceuticals specializes 55 RAF kinase 55 Mucosal 55 TLR9 agonists 55 Kahalalide F 55 GW# [003] 55 bevacizumab Avastin ® 55 rhFVIIa 55 CR# vcMMAE 55 oral isoform selective HDAC 55 polyclonal 55 relapsed leukemia 55 adenoviral 55 HDAC inhibitor 55 subcutaneously administered 55 metaglidasen 55 PDX pralatrexate 55 Amrubicin 55 Hedgehog pathway 55 immunotherapeutics 55 prostate cancer antigen prostatic 55 VZV 55 HDAC 55 leading oral taxane 55 mRNA antagonists 55 AN# novel 55 HCV polymerase inhibitor 55 BAY #-# 55 cancer therapeutics 55 cilengitide 55 Monoclonal antibodies 55 Symphogen 55 potently inhibited 55 S#P# 55 HIV protease inhibitor 54 PRTX 54 Exherin TM 54 activated lymphocytes 54 TTR gene 54 hypoxia activated prodrug 54 hepatitis C virus 54 catalytic antioxidant compounds 54 CBLC# 54 allogeneic cell 54 selective inverse agonist 54 Hsp# inhibitor 54 Tarceva TM 54 nucleotide analog 54 monoclonal anti 54 CYT# 54 IMiDs ® 54 Anticalin R 54 nicotinic acetylcholine receptor 54 cortisol synthesis 54 Scancell 54 PDE4 54 peroxisome proliferator activated 54 Syk kinase 54 immunosuppressive compound 54 CD# receptor 54 perifosine novel potentially 54 vidofludimus 54 TKM ApoB 54 Micromet proprietary BiTE 54 Dalbavancin 54 Bevirimat 54 subunit vaccine 54 Xanafide 54 serine protease 54 DepoVax TM 54 granulocyte macrophage colony stimulating 54 Aganocide 54 anthrax monoclonal antibody 54 PSMA ADC 54 hematological cancers 54 PROfusion 54 rxRNA 54 LY# [002] 54 oxidative stress inducer 54 pertuzumab 54 HGS# 54 vinca alkaloids 54 HDACi 54 tkRNAi technology 54 P#X# antagonist 54 small molecule thrombopoietin 54 botulinum neurotoxin 54 maytansinoid 54 tafamidis 54 monoclonal antibody therapeutics 54 JVRS 54 recombinant vaccine 54 adenovector 54 L Annamycin 54 Myolimus 54 alpha TNF 54 liposomal 54 GM CSF granulocyte 54 PTH analogue 54 antibody therapeutics 54 XL# inhibits 54 antitumor 54 immunoconjugate 54 Orally administered 54 C5aR 54 LymphoStat B TM 54 LHRH antagonists 54 CORT # 54 novel antiviral therapeutics 54 prodrugs 54 allosteric modulators 54 immune modulatory 54 Homspera TM 54 Lixivaptan 54 cytomegalovirus 54 investigational compounds 54 extracellular domain 54 telomerase reverse transcriptase 54 interferon lambda 54 SERMs 54 bioactive lipids 54 S1P 54 antiviral therapies 54 neuroprotective properties 54 milatuzumab 54 affinity antibodies 54 topically applied SEPA 54 virus HCV protease inhibitor 54 Preclinical studies 54 AKT inhibitor 54 Bezielle 54 BZL# 54 selective inhibitors 54 cytostatic 54 preclinical models 54 EGFRvIII 54 Tumour Necrosis Factor 54 selective immunoproteasome inhibitor 54 KSP inhibitor 54 Bortezomib 54 TAFA# 54 oncology therapeutics 54 Onalta 54 Aviptadil 54 small molecule activators 54 direct thrombin inhibitor 54 Nasdaq IMGN biotechnology 54 neutralizing antibody 54 targets Galectin receptors 54 ZEVALIN ® 54 effector function 54 CYP#A# CYP#D# 54 rhIL 7 54 nucleoside reverse transcriptase inhibitor 54 topical anti infective 54 NFkB 54 selective adhesion molecule 54 cyclin dependent kinase inhibitor 54 enzyme inhibitor 54 NS5B polymerase 54 Regado 54 Valortim ® 54 daptomycin 54 MLN# 54 Onco TCS 54 siRNA delivery 54 NS5A 54 Intravenous CP 54 kidney urologic 54 Shiga toxin 54 ASONEP 54 naturally occurring molecule 54 Civacir 54 Silodosin 54 immunomodulatory 54 attach auristatin 54 RDEA# 54 HuMax CD4 54 HspE7 54 integrase inhibitor 54 acting muscarinic antagonist 54 hedgehog pathway 54 USP# 54 Quinamed 54 Janus Kinase 54 teplizumab 54 Thiovir 54 azoles 54 aberrantly activated 54 EndoTAG TM 54 beta lactam 54 novel orally administered 54 Maraviroc 54 butyrylcholinesterase 54 Modified Vaccinia Ankara MVA 54 siRNA binds 54 Allovectin 7 R 54 Akt inhibitor 54 R#/MEM # 54 Anidulafungin 54 TPI ASM8 54 VEGFR2 54 RANKL 54 tiapamil 54 Cyclosert TM 54 ADCC enhanced 54 Thrombin topical Recombinant 54 bacterial enzyme 54 IRX 2 54 Galectin 54 diarrhea predominant irritable 54 recombinant polyclonal antibody 54 intranasal formulation 54 MET amplification 54 Gefitinib 54 VQD 54 FOLOTYN ® 54 ArQule Kinase Inhibitor Platform 54 oral ridaforolimus 54 orally dosed 54 Guanilib 54 injectable formulation 54 calcineurin inhibitors 54 MYDICAR ® 54 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 54 IFN alpha 54 mucosal vaccines 54 Shigamabs ® 54 novel VDA molecule 54 predictive biomarkers 54 enkephalin 54 chemotherapeutic drug 54 monoclonal antibodies mAbs 54 ARRY # 54 nitric oxide donating 54 E2F 54 TLR9 54 PSN# [002] 54 Avila Therapeutics 54 telomerase inhibitor 54 gamma secretase inhibitors 54 intravenously administered 54 tubulin binding 54 lexidronam injection 54 colony stimulating factor 54 biased ligand 54 Survivin antagonist 54 HIV integrase inhibitor 54 infectious diseases autoimmune diseases 54 renin inhibitors 54 Lenocta 54 Trastuzumab 54 inhibits Akt activation 54 CK2 54 Panzem 54 ganciclovir 54 investigational compound 54 elacytarabine 54 drug conjugates ADCs 54 Kuvan sapropterin dihydrochloride 54 Goserelin 54 constitutively activated 54 product platforms AZX# 54 Enhanze TM Technology 54 signal transduction inhibitors 54 RAS MAPK pathway 54 ddRNAi 54 HIV integrase inhibitors 54 HepeX B TM 54 protective antigen 53 dSLIM 53 highly selective endothelin 53 intravesical instillation 53 atacicept 53 adenoviral vectors 53 MAXY G# 53 TRX1 53 c Raf kinase 53 compound PMX # 53 Ii protein 53 nanoparticle formulation 53 cleavable linker 53 Phase III Pivotal 53 CTLs 53 hyaluronidase rHuPH# 53 NeuroVax TM 53 Fodosine 53 Protexia R 53 conserved antigens NP 53 selectively induce apoptosis 53 RGB # 53 thrombin receptor 53 IX Fc fusion 53 mGluR2 NAM 53 BiovaxID 53 receptor CXCR4 53 uPA 53 maturation inhibitor 53 erlotinib Tarceva 53 Ixempra 53 chemokine 53 virotherapy